Zofenopril-d5

Zofenopril-d5 is deuterium labeled Zofenopril. Zofenopril is an angiotensin-converting enzyme (ACE) inhibitor with an IC50 of 81 μM.

Product Specifications

UNSPSC

12352005

Target

Angiotensin-converting Enzyme (ACE) ; Isotope-Labeled Compounds

Type

Isotope-Labeled Compounds

Related Pathways

Metabolic Enzyme/Protease; Others

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Purity

99.92

Solubility

10 mM in DMSO

Smiles

O=C(O)[C@H]1N(C([C@H](C)CSC(C2=C([2H])C([2H])=C([2H])C([2H])=C2[2H])=O)=O)C[C@@H](SC3=CC=CC=C3)C1

Molecular Formula

C22H18D5NO4S2

Molecular Weight

434.58

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Lin CJ, et al. Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: interaction of ACE inhibitors with high-affinity H+/peptide symporter. Pharm Res. 1999 May;16 (5) :609-15.|[3]Sarro GD, et al. Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice. Pharmacol Res. 2012 Mar;65 (3) :285-96.